Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12083164 Amylin analogues

Patent 12083164 was granted and assigned to Zealand Pharma A/S on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Zealand Pharma A/S
Zealand Pharma A/S
0
Date Filed
July 21, 2021
0
Date of Patent
September 10, 2024
0
Patent Applicant
Zealand Pharma A/S
Zealand Pharma A/S
0
Patent Application Number
17381373
0
Patent Citations
‌
US Patent 8741836 Polypeptides
0
‌
US Patent 8895504 Amylin derivatives
0
‌
US Patent 9023789 Amylin analogs and pharmaceutical compositions thereof
0
‌
US Patent 10071140 Amylin analogues
0
‌
US Patent 11382956 Amylin analogues
0
‌
US Patent 10766939 Amylin analogues
0
‌
US Patent 7407934 Methods for regulating postprandial blood glucose
0
‌
US Patent 7910548 Methods for treating obesity
0
‌
US Patent 8575090 Amylin analogues and pharmaceutical compositions thereof
0
‌
US Patent 8575091 Amylin analogues and pharmaceutical compositions thereof
0
•••
Patent Inventor Names
Alexander Heim-Riether
0
Dieter Wolfgang Hamprecht
0
Jesper Mosolff Mathiesen
0
Lise Giehm
0
Henrik Kofoed Munch
0
Giacomo Fossati
0
Jesper Skodborg Villadsen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12083164
0
Patent Primary Examiner
‌
Jeanette M Lieb
0
CPC Code
‌
C07K 14/575
0
‌
A61K 38/22
0

Find more entities like US Patent 12083164 Amylin analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo